TVTX•benzinga•
HC Wainwright & Co. Assumes Travere Therapeutics at Buy, Announces Price Target of $30
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 11, 2025 by benzinga